PharmaBoardroom

Yuichi Yomasu – President, Daiichi Sankyo China

Yuichi Yomasu, president of Daiichi Sankyo China, shares his first impressions of the dynamic but complex Chinese market since he assumed position ten…

Jingsong Wang – CEO, Harbour BioMed, China

Harbour BioMed is a fast-growing global biotech company with facilities in Rotterdam, Boston and Shanghai. The company is laser-focused on developing…

Tian Wee Ng – Managing Director (Asia-Pacific), Pierre…

Tian Wee Ng, managing director (Asia-Pacific) for Pierre Fabre Medicament, shares insight on how the business has evolved in the region, moving from…

Rogers Luo Yongqing – Global VP and General Manager…

Rogers Luo Yongqing, global VP and general manager (China), Gilead Sciences, shares the key accomplishments of Gilead in China with six innovative…

Li Chen – Founder, Executive Director, CEO and CSO, Hua…

While others have failed during the last 30 years, Hua Medicine has finally succeeded in developing a breakthrough diabetes treatment controlling…

Hong Chow – General Manager, Roche Pharma China

Hong Chow, general manager of Roche Pharma China, shares Roche China’s incredible milestones over the past few years, including four pivotal…

First Ever Biosimilar Approval in China: Trouble for Roche?

China’s regulator approved a biosimilar version of Roche’s Rituxan this week, the first such drug ever to be given the green light in the country.…

The Ideal Pharma Country Manager: China (Ardent Search)

The lowdown on what it takes to be a country manager of a multinational pharma company in some of the world’s most challenging markets. Robert Hall…

George Lee – Vice-President of Clinical Operations and…

George Lee, vice-president of clinical operations and country leader of PAREXEL in China, discusses the impact of the recent ownership and management…